Free Trial

NeuroPace (NPCE) SEC Filings & 10K Form

NeuroPace logo
$12.13 -0.17 (-1.38%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$12.16 +0.02 (+0.21%)
As of 03/25/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NeuroPace SEC Filings

DateFilerForm TypeView
03/24/2025
5:10 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
4:16 PM
Becker Joel (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
4:18 PM
Kuhn Rebecca (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:08 PM
Kuhn Rebecca (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:09 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:29 PM
NeuroPace (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2025
4:05 PM
NeuroPace (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
5:51 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
5:52 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
5:31 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
4:41 PM
Kuhn Rebecca (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
8:51 AM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
7:00 AM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
5:33 AM
NeuroPace (Filer)
Form 424B5
02/14/2025
5:08 AM
NeuroPace (Filer)
Form 424B5
02/14/2025
5:11 AM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
11:50 AM
MORGAN STANLEY (Filed by)
NeuroPace (Subject)
Form SCHEDULE 13G/A
01/31/2025
6:16 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
3:11 PM
Morrell Martha (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
3:26 PM
Morrell Martha (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
5:08 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:25 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:30 PM
Morrell Martha (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:43 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:56 PM
Huennekens R Scott (Reporting)
NeuroPace (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
3:57 PM
Huennekens R Scott (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:38 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:30 PM
NeuroPace (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
11/04/2024
3:51 PM
Kent Lake PR LLC (Filed by)
NeuroPace (Subject)
Form SCHEDULE 13G
10/28/2024
6:02 AM
KCK LTD. (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/24/2024
1:23 PM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
9:35 AM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
9:17 AM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:15 PM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:05 PM
KCK LTD. (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:14 PM
NeuroPace (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/10/2024
4:30 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
4:17 PM
NeuroPace (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
3:16 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
5:38 PM
NeuroPace (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
4:10 PM
NeuroPace (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Crypto Market is About to Change Lives (Ad)

We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years.

Claim your FREE book now before it's too late!
04/15/2024
4:25 PM
NeuroPace (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:NPCE) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners